Lam Research (LRCX) – Analysts’ Recent Ratings Changes

Lam Research (NASDAQ: LRCX) recently received a number of ratings updates from brokerages and research firms:

• 1/30/2025 – Lam Research was upgraded by analysts at Cantor Fitzgerald from a “neutral” rating to an “overweight” rating. They now have a $100.00 price target on the stock, up previously from $95.00.
• 1/30/2025 – Lam Research was upgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating. They now have a $91.00 price target on the stock, up previously from $85.00.
• 1/30/2025 – Lam Research had its price target raised by analysts at Wells Fargo & Company from $82.00 to $85.00. They now have an “equal weight” rating on the stock.
• 1/30/2025 – Lam Research had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
• 1/17/2025 – Lam Research was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $95.00 price target on the stock.
• 1/17/2025 – Lam Research had its price target lowered by analysts at Barclays PLC from $90.00 to $75.00. They now have an “equal weight” rating on the stock.
• 1/15/2025 – Lam Research was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating.
• 1/13/2025 – Lam Research had its price target lowered by analysts at Wells Fargo & Company from $83.00 to $82.00. They now have an “equal weight” rating on the stock.
• 1/10/2025 – Lam Research had its price target lowered by analysts at Mizuho from $95.00 to $90.00. They now have an “outperform” rating on the stock.
• 1/10/2025 – Lam Research had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $96.00 to $85.00. They now have a “buy” rating on the stock.
• 12/6/2024 – Lam Research had its price target lowered by analysts at Wells Fargo & Company from $85.00 to $83.00. They now have an “equal weight” rating on the stock.
• 12/5/2024 – Lam Research had its price target raised by analysts at Morgan Stanley from $76.00 to $78.00. They now have an “equal weight” rating on the stock.

Lam Research Stock Performance

NASDAQ LRCX traded down $0.06 on Monday, hitting $80.99. 6,582,378 shares of the stock traded hands, compared to its average volume of 12,658,034. The firm has a market capitalization of $104.21 billion, a price-to-earnings ratio of 24.60, a PEG ratio of 1.34 and a beta of 1.46. The business’s fifty day moving average is $76.05 and its two-hundred day moving average is $78.56. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54. Lam Research Co. has a 12 month low of $68.87 and a 12 month high of $113.00.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. As a group, equities analysts anticipate that Lam Research Co. will post 3.69 EPS for the current fiscal year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 8th. Shareholders of record on Wednesday, December 11th were paid a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 1.14%. The ex-dividend date was Wednesday, December 11th. Lam Research’s dividend payout ratio is presently 27.95%.

Institutional Investors Weigh In On Lam Research

Several large investors have recently added to or reduced their stakes in LRCX. Transcend Capital Advisors LLC lifted its position in Lam Research by 740.4% during the fourth quarter. Transcend Capital Advisors LLC now owns 7,883 shares of the semiconductor company’s stock valued at $569,000 after purchasing an additional 6,945 shares during the last quarter. Bradley Foster & Sargent Inc. CT lifted its holdings in shares of Lam Research by 783.9% during the 4th quarter. Bradley Foster & Sargent Inc. CT now owns 5,551 shares of the semiconductor company’s stock worth $401,000 after acquiring an additional 4,923 shares during the last quarter. Physicians Financial Services Inc. purchased a new position in Lam Research in the fourth quarter worth $508,000. Cassaday & Co Wealth Management LLC increased its stake in Lam Research by 900.0% in the fourth quarter. Cassaday & Co Wealth Management LLC now owns 7,660 shares of the semiconductor company’s stock valued at $553,000 after acquiring an additional 6,894 shares during the last quarter. Finally, Compass Capital Corp MA ADV bought a new stake in Lam Research during the fourth quarter worth about $1,703,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.